Matthew Maxwell Donley Insider Profile

4 Followers
Matthew Maxwell Donley

Matthew Maxwell Donley
Sucampo Pharmaceuticals (SCMP)
EVP, Global HR, IT & Strategy

Ranked #48,480 out of 102,052 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+7.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$253K
100.00%
A breakdown of Matthew Maxwell Donley's holdings

Insider Roles

Aurinia Pharmaceuticals
(AUPH)
Ex VP, Internal Operations
Roles that Matthew Maxwell Donley holds in companies

Most Profitable Insider Trade

Stock:
Aurinia Pharmaceuticals
(AUPH)
Rating:Informative Sell
Date:Mar 04, 2022 - Today
Return:+21.20%
The most profitable trade made by Matthew Maxwell Donley

Matthew Maxwell Donley's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SCMP
Sucampo Pharmaceuticals
Feb 13, 2018
Uninformative Sell
$665.55K
$665.55K
Aurinia Pharmaceuticals
Nov 23, 2022
Ex VP, Internal Operations
Uninformative Buy
$46.60K
$252.74K
List of latest transactions for each holding click on a transaction to see Matthew Maxwell Donley's performance on stock

Matthew Maxwell Donley insider profile FAQ

What is the percentage of profitable transactions made by Matthew Maxwell Donley?
The percentage of profitable transactions made by Matthew Maxwell Donley is 50%.
    What is the average return per transaction made by Matthew Maxwell Donley?
    The average return per transaction made by Matthew Maxwell Donley is 7.50%.
      What stocks does Matthew Maxwell Donley hold?
      Matthew Maxwell Donley holds: SCMP, AUPH stocks.
        What was Matthew Maxwell Donley’s latest transaction?
        Matthew Maxwell Donley latest transaction was an Uninformative Buy of $46.60K.
          What was Matthew Maxwell Donley's most profitable transaction?
          Matthew Maxwell Donley’s most profitable transaction was an Informative Sell of AUPH stock on March 4, 2022. The return on the trade was 21.20%.
            What is Matthew Maxwell Donley's role in Sucampo Pharmaceuticals?
            Matthew Maxwell Donley's role in Sucampo Pharmaceuticals is EVP, Global HR, IT & Strategy.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.